January 27, 2025 - 16:41

FORT WORTH, Texas, Jan. 27, 2025 – Range Resources Corporation has announced the upcoming release of its financial results for the fourth quarter of 2024. The results will be made public on Tuesday, February 25, following the close of trading on the New York Stock Exchange.
In conjunction with this announcement, the company has scheduled a conference call for Wednesday, February 26, at 9:00 a.m. ET (8:00 a.m. CT). During this call, executives will provide insights and analysis regarding the financial performance of the company during the quarter.
This event presents an opportunity for investors, analysts, and other stakeholders to gain a deeper understanding of the company’s financial health and strategic direction. Participants are encouraged to prepare questions in advance to engage with the management team effectively. The company aims to provide a comprehensive overview of its operations and future outlook during this important discussion.
October 9, 2026 - 23:32
Chancellor Placed on Leave Following Financial Misconduct ClaimsThe chancellor of a San Francisco college has been placed on administrative leave while officials examine allegations of financial misconduct. The decision was announced as a temporary measure, and...
October 9, 2026 - 09:12
Finance Hiring Still Favors Degree Holders for Top Paying RolesRecruiters filling the highest paying jobs in finance continue to treat a university degree as a basic requirement, even as some employers experiment with skills based hiring. The preference is...
October 8, 2026 - 18:33
Enova Announces Date of Third Quarter 2026 Financial Results Conference CallEnova International has scheduled the release of its third quarter 2026 financial results for Thursday, October 22, 2026. The company will publish the report after the stock market closes that day,...
October 8, 2026 - 08:18
Celcuity (CELC) Is Down 17.3% After REVTORPYK US Launch And sNDA Filing News EventCelcuity Inc. saw its shares drop 17.3 percent after the company announced two significant developments regarding its breast cancer treatment. The company confirmed that REVTORPYK, also known as...